BME | VHT | BME / VHT | |
Gain YTD | 1.422 | -0.294 | -484% |
Net Assets | 505M | 17B | 3% |
Total Expense Ratio | 1.10 | 0.09 | 1,222% |
Turnover | 29.00 | 4.00 | 725% |
Yield | 0.32 | 1.65 | 19% |
Fund Existence | 20 years | 22 years | - |
BME | VHT | |
---|---|---|
RSI ODDS (%) | N/A | N/A |
Stochastic ODDS (%) | 4 days ago78% | 4 days ago77% |
Momentum ODDS (%) | 4 days ago75% | 4 days ago80% |
MACD ODDS (%) | 4 days ago71% | 4 days ago77% |
TrendWeek ODDS (%) | 4 days ago76% | 4 days ago81% |
TrendMonth ODDS (%) | 4 days ago76% | 4 days ago81% |
Advances ODDS (%) | 6 days ago76% | 4 days ago82% |
Declines ODDS (%) | 12 days ago80% | 12 days ago84% |
BollingerBands ODDS (%) | 4 days ago79% | 4 days ago79% |
Aroon ODDS (%) | 4 days ago80% | 4 days ago82% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
CDEI | 76.90 | N/A | N/A |
Calvert US Large-Cp Div, Eq AndIncETF | |||
SBI | 7.67 | -0.01 | -0.07% |
Western Asset Intermediate Muni Fund | |||
LRGE | 80.97 | -0.09 | -0.12% |
ClearBridge Large Cap Growth Select ETF | |||
TOV | 27.07 | -0.10 | -0.35% |
JLens 500 Jewish Advocacy U.S. ETF | |||
EWU | 41.27 | -0.23 | -0.55% |
iShares MSCI United Kingdom ETF |
A.I.dvisor tells us that BME and DHR have been poorly correlated (+16% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BME and DHR's prices will move in lockstep.
Ticker / NAME | Correlation To BME | 1D Price Change % | ||
---|---|---|---|---|
BME | 100% | +1.60% | ||
DHR - BME | 16% Poorly correlated | +0.34% | ||
UNH - BME | 12% Poorly correlated | +11.85% | ||
ABBV - BME | 12% Poorly correlated | +0.98% | ||
ABT - BME | 10% Poorly correlated | +1.91% | ||
AMGN - BME | 9% Poorly correlated | +2.13% | ||
More |
A.I.dvisor indicates that over the last year, VHT has been closely correlated with TMO. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if VHT jumps, then TMO could also see price increases.